natgillin/translations-raw huggingface dataset:
Important information about some of the ingredients of Clopidogrel 1A Pharma:
Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel 1A Pharma
Important information about some of the ingredients of Clopidogrel Acino Pharma:
Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel Acino Pharma
Important information about some of the ingredients of Clopidogrel BMS:
Pomembne informacije o nekaterih sestavinah zdravila Clopidogrel BMS
Important information about some of the ingredients of Clopidogrel HEXAL:
Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel HEXAL
Important information about some of the ingredients of Clopidogrel Sandoz:
Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel Sandoz
Important information about some of the ingredients of Clopidogrel Teva Generics B.V. Clopidogrel Teva Generics B.V. contains hydrogenated castor oil which may cause stomach upset and diarrhoea.
Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel Teva Generics B.V. Zdravilo Klopidogrel Teva Generics B.V. vsebuje hidrogenirano ricinusovo olje, ki lahko povzroči želodčne motnje ali drisko.
Important information about some of the ingredients of Defitelio
Pomembne informacije o nekaterih sestavinah zdravila Defitelio
Important information about some of the ingredients of Diacomit
Pomembne informacije o nekaterih sestavinah zdravila Diacomit
Important information about some of the ingredients of Diacomit”.
Pomembne informacije o nekaterih sestavinah zdravila Diacomit“.
Important information about some of the ingredients of EDURANT
Pomembni podatki o sestavinah zdravila EDURANT
Important information about some of the ingredients of Exelon
Pomembne informacije o nekaterih sestavinah zdravila Exelon
Important information about some of the ingredients of Eylea
Pomembne informacije o nekaterih sestavinah zdravila Eylea
Important information about some of the ingredients of FABLYN
Pomembne informacije o nekaterih sestavinah zdravila FABLYN
Important information about some of the ingredients of Filgrastim ratiopharm
Pomembne informacije o nekaterih sestavinah zdravila Filgrastim ratiopharm
Important Information about some of the Ingredients of FORCALTONIN
Pomembni podatki o nekaterih sestavinah FORCALTONINA
Important information about some of the ingredients of FORSTEO:
Pomembne informacije o nekaterih sestavinah zdravila FORSTEO
Important information about some of the ingredients of GONAL-f
Pomembne informacije o nekaterih sestavinah zdravila GONAL-f
Important information about some of the ingredients of Grastofil
Pomembne informacije o nekaterih sestavinah zdravila Grastofil
Important information about some of the ingredients of HUMENZA
Pomembne informacije o nekaterih sestavinah cepiva HUMENZA
Important information about some of the ingredients of Hycamtin
Pomembne informacije o nekaterih sestavinah zdravila Hycamtin
Important information about some of the ingredients of INCIVO
Pomembne informacije o nekaterih sestavinah zdravila INCIVO
Important information about some of the ingredients of Infanrix Penta
Pomembne informacije o nekaterih sestavinah cepiva Infanrix Penta
Important information about some of the ingredients of Insuman Implantable
Pomembne informacije o nekaterih sestavinah zdravila Insuman Implantable
Important information about some of the ingredients of Insuman Rapid
Pomembne informacije o nekaterih sestavinah zdravila Insuman Rapid
Important information about some of the ingredients of IntronA
Pomembne informacije o nekaterih sestavinah zdravila IntronA
Important information about some of the ingredients of Irbesartan BMS
Pomembne informacije o nekaterih sestavinah zdravila Irbesartan BMS
Important information about some of the ingredients of Kadcyla
Pomembne informacije o nekaterih sestavinah zdravila Kadcyla
Important information about some of the ingredients of Levetiracetam Accord
Pomembne informacije o nekaterih sestavinah zdravila Levetiracetam Accord
Important information about some of the ingredients of LUMIGAN 0.1 mg/ml
Pomembne informacije o nekaterih sestavinah zdravila LUMIGAN 0,1 mg/ml
Important information about some of the ingredients of LUMIGAN 0.3 mg/ml
Pomembne informacije o nekaterih sestavinah zdravila LUMIGAN 0,3 mg/ml
Important information about some of the ingredients of Luveris
Pomembne informacije o nekaterih sestavinah zdravila Luveris
Important information about some of the ingredients of Lyxumia
Pomembne informacije o nekaterih sestavinah zdravila Lyxumia
Important information about some of the ingredients of Macugen
Pomembne informacije o nekaterih sestavinah zdravila Macugen
Important information about some of the ingredients of MIRCERA
Pomembne informacije o nekaterih sestavinah zdravila MIRCERA
Important information about some of the ingredients of Neupopeg
Pomembne informacije o nekaterih sestavinah zdravila Neulasta
Important information about some of the ingredients of Neupopeg
Pomembne informacije o nekaterih sestavinah zdravila Neupopeg
Important information about some of the ingredients of Norvir
Pomembne informacije o nekaterih sestavinah zdravila Norvir
Important information about some of the ingredients of NovoRapid
Pomembne informacije o nekaterih sestavinah zdravila NovoRapid
Important information about some of the ingredients of NULOJIX
Pomembne informacije o nekaterih sestavinah zdravila NULOJIX
Important information about some of the ingredients of Olanzapine Teva
Pomembne informacije o nekaterih sestavinah zdravila Olanzapin Teva
Important information about some of the ingredients of Onsenal:
Pomembne informacije o nekaterih sestavinah zdravila Onsenal
Important information about some of the ingredients of Opsumit
Pomembne informacije o nekaterih sestavinah zdravila Opsumit
Important information about some of the ingredients of Osigraft
Pomembne informacije o nekaterih sestavinah zdravila Osigraft
Important information about some of the ingredients of Ovaleap
Pomembne informacije o nekaterih sestavinah zdravila Ovaleap
Important information about some of the ingredients of Ovitrelle
Pomembne informacije o nekaterih sestavinah zdravila Ovitrelle
Important information about some of the ingredients of Palonosetron Accord
Pomembne informacije o nekaterih sestavinah v zdravilu Palonosetron Accord
Important information about some of the ingredients of Pedea
Pomembne informacije o nekaterih sestavinah zdravila Pedea
Important information about some of the ingredients of PegIntron
Pomembne informacije o nekaterih sestavinah zdravila PegIntron
Important information about some of the ingredients of Posaconazole SP
Pomembne informacije o nekaterih sestavinah zdravila Posaconazole SP
Important information about some of the ingredients of Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg
Pomembne informacije o nekaterih sestavinah cepiva Prepandemično cepivo proti gripi (H5N1) (z delci virionov, inaktivirano, z adjuvansom) GlaxoSmithKline Biologicals 3,75 µg
Important information about some of the ingredients of Prevenar:
Pomembne informacije o nekaterih sestavinah cepiva Prevenar:
Important information about some of the ingredients of PROCYSBI
Pomembne informacije o nekaterih sestavinah zdravila PROCYSBI
Important information about some of the ingredients of Prometax
Pomembne informacije o nekaterih sestavinah zdravila Prometax
Important information about some of the ingredients of Quixidar
Pomembne informacije o nekaterih sestavinah zdravila Quixidar
Important information about some of the ingredients of Relistor
Pomembne informacije o nekaterih sestavinah zdravila Relistor
Important information about some of the ingredients of Revasc
Pomembne informacije o nekaterih sestavinah zdravila Revasc
Important information about some of the ingredients of Riprazo HCT
Pomembne informacije o nekaterih sestavinah zdravila Riprazo HCT
Important information about some of the ingredients of Sabe rvel
Pome mbne informacije o nekaterih sestavinah zdravila Sabe rvel
Important information about some of the ingredients of Sepioglin
Pomembne informacije o nekaterih sestavinah zdravila Sepioglin
Important information about some of the ingredients of Sialanar
Pomembne informacije o nekaterih sestavinah zdravila Sialanar
Important information about some of the ingredients of Signifor
Pomembne informacije o nekaterih sestavinah zdravila Signifor
Important information about some of the ingredients of Sprimeo HCT
Pomembne informacije o nekaterih sestavinah zdravila Sprimeo HCT
Important information about some of the ingredients of Stivarga
Pomembne informacije o nekaterih sestavinah zdravila Stivarga
Important information about some of the ingredients of Strensiq
Pomembne informacije o nekaterih sestavinah zdravila Strensiq
Important information about some of the ingredients of Thelin
Pomembne informacije o nekaterih sestavinah zdravila Thelin
Important information about some of the ingredients of Toujeo
Pomembne informacije o nekaterih sestavinah zdravila Toujeo
Important information about some of the ingredients of Tracleer
Pomembne informacije o nekaterih sestavinah zdravilaTracleer
Important information about some of the ingredients of Trazec
Pomembne informacije o nekaterih sestavinah zdravila Trazec
Important information about some of the ingredients of Tresiba
Pomembne informacije o nekaterih sestavinah zdravila Tresiba
Important information about some of the ingredients of TREVICTA
Pomembne informacije o nekaterih sestavinah zdravila TREVICTA
Important information about some of the ingredients of Tritanrix HepB
Pomembne informacije o nekaterih sestavinah cepiva Tritanrix HepB
Important information about some of the ingredients of Trudexa
Pomembne informacije o nekaterih sestavinah zdravila Trudexa
Important information about some of the ingredients of Valtropin
Pomembne informacije o nekaterih sestavinah zdravila Valtropin:
Important information about some of the ingredients of Vaniqa
Pomembne informacije o nekaterih sestavinah zdravila Vaniqa
Important information about some of the ingredients of VIBATIV
Pomembne informacije o nekaterih sestavinah zdravila VIBATIV
Important information about some of the ingredients of Vimpat
Pomembne informacije o nekaterih sestavinah zdravila Vimpat
Important information about some of the ingredients of Viraferon
Pomembne informacije o nekaterih sestavinah zdravila Viraferon
Important information about some of the ingredients of ViraferonPeg
Pomembne informacije o nekaterih sestavinah zdravila ViraferonPeg
Important information about some of the ingredients of Vivanza 10 mg orodispersible tablets:
Pomembne informacije o nekaterih sestavinah zdravila Vivanza 10 mg orodisperzibilne tablete
Important information about some of the ingredients of Wilzin
Pomembne informacije o nekaterih sestavinah zdravila Wilzin
Important information about some of the ingredients of Xeplion
Pomembne informacije o nekaterih sestavinah zdravila Xeplion
Important information about some of the ingredients of Xigris
Pomembne informacije o nekaterih sestavinah zdravila Xigris
Important information about some of the ingredients of Zerene
Pomemben podatek o nekaterih sestavinah zdravila Zerene
Important information about some of the ingredients of ZIMULTI
Pomembne informacije o nekaterih sestavinah zdravila ZIMULTI
Important information about some of the ingredients of Zonegran Zonegran contains aspartame (E951)
Pomembne informacije o nekaterih sestavinah zdravila Zonegran Zdravilo Zonegran vsebuje aspartam (E951)
Important information about some of the ingredients of Zonegran Zonegran contains sunset yellow FCF (E110) and allura red AC (E129)
Pomembne informacije o nekaterih sestavinah zdravila Zonegran
Important information about some of the ingredietns of Relistor
Pomembne informacije o nekaterih sestavinah zdravila Relistor
Important information about some of the other ingredients of Kivexa tablets
Pomembne informacije o nekaterih sestavinah Kivexa tablet
Important information about your asthma symptoms
Pomembne informacije o simptomih astme
Important information for Step A of the injecting process.
Pomembno pri koraku A postopka injiciranja
Important information for use of OptiSet:
Pomembne informacije za uporabo OptiSeta:
Important information for use of SoloStar:
Shematični prikaz injekcijskega peresnika Pomembne informacije za uporabo SoloStarja:
Important information regarding medicinal product interactions when ritonavir is used a pharmacokinetic enhancer is also contained in the Summary of Product Characteristics of the co- administered protease inhibitor.
Pomembne informacije o medsebojnem delovanju zdravil med uporabo ritonavirja kot farmakokinetičnega stopnjevalca vsebuje tudi povzetek glavnih značilnosti sočasno uporabljenega zaviralca proteaz.
Important information to know before you start
Pomembne informacije, ki jih morate vedeti pred začetkom
Important Instructions when using BRINAVESS
Pomembna navodila pri uporabi zdravila BRINAVESS
Important note: Do not flush infusion lines into the patient, as it will cause an inadvertent bolus of BLINCYTO to be administered.
Pomembna opomba: Infuzijske linije ne izpirajte v bolnika, ker lahko s tem bolniku aplicirate nenameren bolus zdravila BLINCYTO.
Important Note: Do not flush infusion lines into the patient, as it will cause an inadvertent bolus of BLINCYTO to be administered.
Pomembna opomba: Infuzijske linije ne izpirajte v bolnika, ker lahko s tem povzročite nenamerno aplikacijo bolusa zdravila BLINCYTO.
Important Notes
Pomembna opozorila
Important safety information
Pomembna opozorila za varno uporabo
Important Safety Reminders for Patients taking Ferriprox (deferiprone)
Pomembna opozorila glede varnosti bolnikov, ki jemljejo zdravilo Ferriprox (deferipron)
Important signs to look after administration of HEMANGIOL Risk of hypotension and bradycardia (low heart rate)
Pomembni znaki, na katere morate biti pozorni po dajanju zdravila HEMANGIOL Tveganje za hipotenzijo in bradikardijo (počasen srčni utrip)
Important skin pinch technique
Pomembno: naredite kožno gubo
Important things to be aware of
Pomembne informacije, ki jih je treba upoštevati
Important things to know about combined hormonal contraceptives (CHCs):
Pomembne informacije, ki jih morate vedeti o kombiniranih hormonskih kontraceptivih (CHC – combined hormonal contraceptives):
Important things to know about combined hormonal contraceptives (CHCs):
Pomembne informacije, ki jih morate vedeti o kombiniranih hormonskih kontraceptivih (CHC, combined hormonal contraceptives):
Important things to know before you use this medicine:
Pomembne stvari, ki jih morate vedeti pred začetkom uporabe tega zdravila
Important things to know while you are using this medicine:
Pomembne stvari, ki jih morate vedeti med uporabo tega zdravila
Important tips to keep in mind
Pomembni napotki
Important warning signs of potential side effects such as low blood pressure, low heart rate, low blood sugar level, and bronchospasm should be looked after following administration of HEMANGIOL.
Po dajanju zdravila HEMANGIOL je treba biti pozoren na pomembne opozorilne znake morebitnih neželenih učinkov, npr. nizek krvni tlak, nizek srčni utrip, nizko raven sladkorja v krvi in bronhospazem.
IMPORTANT — Hypersensitivity reactions
POMEMBNO – Preobčutljivostne reakcije
IMPORTANT — Hypersensitivity reactions
POMEMBNO — Preobčutljivostne reakcije
IMPORTANT — Use the medicine immediately after you have mixed the powder with water.
POMEMBNO — Zdravilo uporabite takoj po tem, ko prašek zmešate z vodo.
IMPORTANT: Because some medicine will remain in the mixing bottle, complete the following steps.
POMEMBNO: Nekaj zdravila ostane v mešalni plastenki, zato morate izvesti še naslednja dva koraka.
Important: Check to make sure that the needle is completely retracted.
Pomembno: Preverite, če se je igla zares v celoti povrnila v prvotno lego.
Important: Do not allow the administration system to come into contact with water.
Pomembno: Aplikacijski sistem ne sme priti v stik z vodo.
Important: Do not remove the battery from the battery case.
Pomembno: Ne ločite baterije od ohišja.
Important: Do not store the administration system unrefrigerated for more than 6 hours.
Pomembno: Ne pustite aplikacijskega sistema zunaj hladilnika več kot 6 ur.
Important: do not try to give yourself an injection unless you have received training from your doctor or nurse.
Pomembno: ne poskušajte si dati injekcijo, če prej niste bili deležni usposabljanja s strani vašega zdravnika ali medicinske sestre.
Important: If the adhesive pad does not stick properly to the skin the injection cannot be started.
Pomembno: Če se lepljiva podlaga ni dobro prijela kože, se injiciranje ne more začeti.
Important: Place the administration system horizontally across the thigh as pictured, DO NOT place the administration system lengthwise on the thigh.
Pomembno: Aplikacijski sistem namestite prečno preko stegna kot na sliki; NE nameščajte ga vzdolž stegna.
IMPORTANT: READ ENCLOSED PACKAGE LEAFLET
POMEMBNO: PREBERITE PRILOŽENO NAVODILO ZA UPORABO
Importantly, growth factor support was not routinely required and transfusions with red blood cells and platelets were uncommon. (See section 4.4)
Pomembno je, da podpora z rastnimi faktorji ni bila rutinsko potrebna ter da so bile transfuzije eritrocitov in trombocitov občasne. (Glejte poglavje 4.4.)
Importantly, such symptoms may lead to misdiagnosis of HSR as respiratory disease (pneumonia, bronchitis, pharyngitis), or gastroenteritis .
Pomembno je, da lahko takšni simptomi povzročijo napačno prepoznavo HSR kot bolezni dihal (pljučnica, bronhitis, faringitis) ali kot gastroenteritisa.
Importantly, such symptoms may lead to misdiagnosis of HSR as respiratory disease (pneumonia, bronchitis, pharyngitis), or gastroenteritis.
Pomembno je, da lahko takšni simptomi povzročijo napačno prepoznavo HSR kot bolezni dihal (pljučnica, bronhitis, faringitis) ali kot gastroenteritisa.
Impotence
dojkah
Impotence
impotenca
Impotence
nuja za mokrenje
Impotence
periferni edem
Impotence
zastoj seča
impotence inflammations
impotenca vnetja
impotence, abnormally heavy or extended menstrual flow or a lack of menstruation;
impotenca, nenormalno močna ali podaljšana menstrualna krvavitev ali odsotnost menstruacije;
Impotence, gynaecomastia
impotenca, ginekomastija
impotence; inflammations.
impotenca; vnetja.
Impotenceam, gynaecomastiaam
impotencaam, ginekomastijaam
Impotenceh
impotencah
Imprida HCT 10 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Imprida HCT 10 mg/160 mg/12,5 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Imprida HCT 10 mg/160 mg/12.5 mg film-coated tablets are pale yellow, oval tablets with “NVR” on one side and “VDL” on the other side.
Imprida HCT 10 mg/160 mg/12,5 mg filmsko obložene tablete so bledo rumene ovalne tablete z oznako “NVR” na eni strani in “VDL” na drugi.
Imprida HCT 10 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Imprida HCT 10 mg/160 mg/25 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Imprida HCT 10 mg/160 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VHL” on the other side.
Imprida HCT 10 mg/160 mg/25 mg filmsko obložene tablete so rjavo rumene ovalne tablete z oznako “NVR” na eni strani in “VHL” na drugi.
Imprida HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Imprida HCT 10 mg/320 mg/25 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Imprida HCT 10 mg/320 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VFL” on the other side.
Imprida HCT 10 mg/320 mg/25 mg filmsko obložene tablete so rjavo rumene ovalne tablete z oznako “NVR” na eni strani in “VFL” na drugi.
Imprida HCT 5 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Imprida HCT 5 mg/160 mg/12,5 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Imprida HCT 5 mg/160 mg/12.5 mg film-coated tablets are white, oval tablets with “NVR” on one side and “VCL” on the other side.
Imprida HCT 5 mg/160 mg/12,5 mg filmsko obložene tablete so bele ovalne tablete z oznako “NVR” na eni strani in “VCL” na drugi.
Imprida HCT 5 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Imprida HCT 5 mg/160 mg/25 mg filmsko obložene tablete amlodipin/valsartan/hidroklorotiazid
Imprida HCT 5 mg/160 mg/25 mg film-coated tablets are yellow, oval tablets with “NVR” on one side and “VEL” on the other side.
Imprida HCT 5 mg/160 mg/25 mg filmsko obložene tablete so rumene ovalne tablete z oznako “NVR” na eni strani in “VEL” na drugi.
Imprida HCT and older people (age 65 years and older)
Zdravilo Imprida HCT in starejši ljudje (stari 65 let in več)
Imprida HCT can be used by people aged 65 years and over at the same dose as for other adults and in the same way as they have already taken the three substances called amlodipine, valsartan and hydrochlorothiazide.
Ljudje, ki so stari 65 let ali več, lahko uporabljajo zdravilo Imprida HCT v enakih odmerkih kot drugi odrasli in na povsem enak način, kot so prej jemali tri učinkovine amlodipin, valsartan in hidroklorotiazid.
Imprida must not be used in patients who are hypersensitive (allergic) to amlodipine or other medicines in the ‘dihydropyridine derivatives’ class, to valsartan, or to any of the other ingredients.
Zdravila Imprida ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) amlodipin ali druga zdravila iz razreda derivatov dihidropiridina, valsartan ali katero koli drugo sestavino zdravila.
Imprint
Oznaka
Imprints
Vtisnjene oznake
Improper patient selection (e.g., use in patients without maintenance opioid therapy) and/or improper dosing have resulted in fatal outcome with Effentora as well as with other fentanyl products.
Neustrezen izbor bolnikov (na primer uporaba pri bolnikih brez vzdrževalne terapije z opioidi) in/ali neprimerno odmerjanje lahko z zdravilom Effentora in drugimi zdravili, ki vsebujejo fentanil, povzroči smrten izid.
Improvac also contains an adjuvant (a chemical derived from the sugar dextran).
Zdravilo Improvac vsebuje tudi adjuvans (kemično spojino, pridobljeno iz sladkorja dekstran).
Improvac has been shown to be safe in male pigs from 8 weeks of age onwards.
Improvac je pokazal varno uporabo pri živalih v starosti od 8 tednov dalje.
Improvac is an immunological product intended for male pigs that contains a gonadotropin releasing factor (GnRF) analogue-protein conjugate as the active substance.
Zdravilo Improvac je imunološko sredstvo, namenjeno prašičem samcem, kot zdravilno učinkovino pa vsebuje analog gonadotropin sproščajočega faktorja (GnRF) – konjugirani protein.
Improvac is an immunological product which has an action mode similar to that of a vaccine (stimulates the immune system to produce antibodies).
Zdravilo Improvac je imunološko zdravilo, ki deluje podobno kot cepivo (spodbuja imunski sistem, da začne proizvajati protitelesa).
Improvac is given to young male pigs as two doses, with at least a 4 week interval.
Zdravilo Improvac se daje mladim prašičem samcem v dveh odmerkih z vsaj 4-tedenskim presledkom.
Improvac is used as an alternative to physical castration (removal of the testicles) to reduce the presence of these compounds.
Zdravilo Improvac se uporablja kot alternativa fizični kastraciji (odstranitvi testisov) za zmanjšanje prisotnosti teh spojin.
Improvac is used to reduce ‘boar taint’ in the meat obtained from male pigs.
Zdravilo Improvac se uporablja za zmanjšanje vonja po merjascu v mesu, ki se pridobiva iz prašičev samcev.
Improvac must not be given to pigs by women who are or who may be pregnant.
Zdravila Improvac prašičem ne smejo dajati nosečnice ali ženske, ki bi lahko bile noseče.
Improvac must not be used in female pigs or in male pigs intended for breeding.
Zdravilo se ne sme uporabljati pri svinjah ali prašičih samcih, ki so namenjeni za razplod.
Improvac solution for injection
Improvac raztopina za injiciranje
Improvac solution for injection for pigs
Improvac raztopina za injiciranje za prašiče
Improvac, solution for injection for pigs
Improvac raztopina za injiciranje